Our Experts

Julia Scanlan

Associate Solution Consultant

Expertise: Biosimilars, Payer Market Research, Industry Trends

Julia Scanlan is an Associate Solution Consultant at MMIT. Previously, she worked in the company’s Data Operations team and then Market Research as an analyst and advisory consultant. She holds a bachelor’s degree in Public Health from Brigham Young University.

⟨ Back to Our Experts

Insights by Julia Scanlan

Article | January 16, 2025

Growing Interest in Direct-to-Consumer Drug Programs

The past few years saw the launch of several direct-to-consumer (DTC) programs, including Amazon One Medical and Mark Cuban’s Cost Plus Drugs. In 2024, several manufacturer-designed DTC programs, such as LillyDirect and PfizerForAll, have been added to the mix, demonstrating pharma’s continuing shift toward an integrated model of patient care.

Article | April 11, 2024

Cordavis Could Benefit U.S. Biosimilars Market

It has now been over a year since the first Humira biosimilar, Amgen’s Amjevita, entered the U.S. market. Eight additional adalimumab biosimilars followed suit, offering lower-cost alternatives to AbbVie’s blockbuster drug via a variety of dual-pricing and discounting strategies.

Article | November 30, 2023

Humira Biosimilars: Pricing, Contracting and Interchangeability

This has been a significant year for the Humira (adalimumab) biosimilar market. AbbVie’s blockbuster drug Humira, an injectable used to treat a range of inflammatory conditions, saw the end of its 20-year, $200 billion monopoly in January.

Article | May 4, 2023

Coping With Drug Shortages: How Payers and Manufacturers Can Support Continued Patient Access

The COVID-19 pandemic illuminated a challenge to the U.S. healthcare system that continues to undermine effective patient care: medication shortages. A Senate report found that drug shortages increased nearly 30% last year, with a record five-year high of 295 active drug shortages by the end of 2022.

Real-World Data Solutions

Payer Data Intelligence Solutions

Payer and Provider Insights Solutions

Payer and Specialty Pharmacy Solutions

Promotional Solutions

Market Access

Patient Journey

Brand Performance and Strategy

Contracting and Reimbursement